In this randomized controlled trial, the participants who took myo-inositol had a lower risk of developing gestational diabetes, though methodological flaws reduce confidence in these results.
This Study Summary was published on December 5, 2024.
In this randomized controlled trial, the participants who took myo-inositol had a lower risk of developing gestational diabetes, though methodological flaws reduce confidence in these results.
This Study Summary was published on December 5, 2024.
